{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:10:25Z","timestamp":1781277025872,"version":"3.54.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,19]]},"DOI":"10.1093\/ehjopen\/oeab005","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T15:45:27Z","timestamp":1627573527000},"source":"Crossref","is-referenced-by-count":4,"title":["Targeting cytokine storm in COVID-19: what have we learned?"],"prefix":"10.1093","volume":"1","author":[{"given":"Paul M","family":"Ridker","sequence":"first","affiliation":[{"name":"Department of Medicine, Center for Cardiovascular Disease Prevention, Brigham and Women\u2019s Hospital, Harvard Medical School , 900 Commonwealth Avenue, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"2023041318210146100_","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"2023041318210146100_","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19: preliminary report","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"N Eng J Med"},{"key":"2023041318210146100_","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe Covid-19 pneumonia","volume":"384","author":"Rosas","year":"2021","journal-title":"N Engl J Med"},{"key":"2023041318210146100_","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","article-title":"Efficacy of tocilizumab in patients hospitalized with COVID-19","volume":"383","author":"Stone","year":"2020","journal-title":"N Engl J Med"},{"key":"2023041318210146100_","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N Engl J Med"},{"key":"2023041318210146100_","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with COVID-19","volume":"384","author":"The REMAP-CAP Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"2023041318210146100_","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomized, controlled, open-label, platform trial","volume":"397","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"Lancet"},{"key":"2023041318210146100_","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeab002","article-title":"Double-blind randomised proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation","author":"Cremer","year":"2021","journal-title":"Eur Heart J Open"},{"key":"2023041318210146100_","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2023041318210146100_","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00222-8","article-title":"Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial","author":"Tardif","year":"2021","journal-title":"Lancet Respir Med"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjopen\/advance-article-pdf\/doi\/10.1093\/ehjopen\/oeab005\/39456197\/oeab005.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/1\/1\/oeab005\/49881169\/oeab005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/1\/1\/oeab005\/49881169\/oeab005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T16:57:38Z","timestamp":1699289858000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oeab005\/6330622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,8,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oeab005","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,7,29]]},"article-number":"oeab005"}}